货号：UP268551243
| 产品信息 | |
| 产品名称： | LDE225 Diphosphate |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 1218778-77-8 |
| 分子式： | C26H32F3N3O11P2 |
| 分子量： | 681.49 |
| MDL NO： | - |
| 标准纯度： | 98+% (UP268551243) |
| 沸点： | - |
| 储存： | (UP268551243) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
BAY-707
UP9923681092109805-96-9
RGB-286638 free base
UP173440703784210-88-4
alpha-Viniferin
UP94366996062218-13-7
PP1
UP626269725172889-26-8
Telcagepant
UP411159673781649-09-0
Edrophonium chloride
UP195173369116-38-1
PJ34 hydrochloride
UP974288188344458-15-7
DC_517
UP843285066500017-70-9
SAG
UP772693345912545-86-9
Lomeguatrib
UP239155508192441-08-0
PQ401
UP271510203196868-63-0
GSK503
UP7571185431346572-63-1
KX2-391
UP590933772897016-82-9
SN-38
UP24180905286639-52-3
CHIR-124
UP175169455405168-58-3
BGJ398
UP772276464872511-34-7
BMS-754807
UP3434371151001350-96-4
3,3'-Diindolylmethane
UP9309214421968-05-4
Glucose-conjugated MGMT inhibitor
UP291559118382607-78-5
Androgen Receptor Modulator C7
UP3906364822109805-69-6
GSK1904529A
UP3267917321089283-49-7
1-[2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolyl]-4-piperidinamine
UP816821747670220-88-9
(+)-Apogossypol
UP44574431466389-74-0
Treosulfan
UP548557455299-75-2
MCB-613
UP6922091901162656-22-5
RI-2
UP9015306071417162-36-7
Amezinium methylsulfate
UP21110884730578-37-1
NCD-38
UP2047064411456907-39-3
Risperidone
UP718712226106266-06-2
Galaterone
UP276614188851983-85-2
Talnetant
UP267846623174636-32-9
TG 101209
UP619552355936091-14-4
N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-(pyridin-2-yl)phenyl)acetamide
UP870585246348086-71-5
LOXO-101 sulfate
UP7557934351223405-08-0
TG 100801
UP664638334867331-82-6
PD0166285
UP188519090185039-89-8
CPI-203
UP6435424701446144-04-2
c-FMS inhibitor
UP505838475885704-21-2
Aripiprazole
UP348272145129722-12-9
FLI-06
UP805517879313967-18-9
Oxaliplatin
UP91986032461825-94-3
WEHI-345 analog
UP2578414571354825-62-9
XL228
UP453643798898280-07-4
TH588 HCl
UP9453529501640282-30-9
Oxolinic acid
UP16486358014698-29-4
(1S-cis)-Milnacipran Hydrochloride
UP522421577175131-60-9
TRC051384 Hydrochloride
UP3640851771333327-56-2
SGI-1027
UP9371621601020149-73-8
BAR501
UP7983581271632118-69-4
PD-1-PDL1 Inhibitor C1a Hydrochloride
UP8498958622108101-94-4
Topotecan hydrochloride
UP680282099119413-54-6
ML324
UP3621026231222800-79-4
Savolitinib
UP7469594211313725-88-0
BX795
UP186999293702675-74-9
AC710
UP3119440641351522-04-7
Pexidartinib
UP7440864661029044-16-3
Lomustine
UP95386936213010-47-4
Sertraline hydrochloride
UP95578996379559-97-0
Doxazosin Mesylate
UP68690477477883-43-3
LDE225 Diphosphate
UP2685512431218778-77-8